CD1 and mycobacterial lipids activate human T cells

被引:66
作者
Van Rhijn, Ildiko [1 ,2 ,3 ]
Moody, D. Branch [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02445 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands
关键词
CD1; mycolyl lipids; T cells; T-cell receptor; Mycobacterium tuberculosis; HUMAN DENDRITIC CELLS; DIFFERENT INTRACELLULAR COMPARTMENTS; ANTIGEN-PRESENTING MOLECULES; LIPOGLYCAN ANTIGENS; CRYSTAL-STRUCTURE; IMMUNE-RESPONSES; BINDING GROOVE; GUINEA-PIG; PHOSPHATIDYLINOSITOL MANNOSIDE; EFFICIENT PRESENTATION;
D O I
10.1111/imr.12253
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
For decades, proteins were thought to be the sole or at least the dominant source of antigens for T cells. Studies in the 1990s demonstrated that CD1 proteins and mycobacterial lipids form specific targets of human T cells. The molecular basis by which T-cell receptors (TCRs) recognize CD1-lipid complexes is now well understood. Many types of mycobacterial lipids function as antigens in the CD1 system, and new studies done with CD1 tetramers identify T-cell populations in the blood of tuberculosis patients. In human populations, a fundamental difference between the CD1 and major histocompatibility complex systems is that all humans express nearly identical CD1 proteins. Correspondingly, human CD1 responsive T cells show evidence of conserved TCRs. In addition to natural killer T cells and mucosal-associated invariant T (MAIT cells), conserved TCRs define other subsets of human T cells, including germline-encoded mycolyl-reactive (GEM) T cells. The simple immunogenetics of the CD1 system and new investigative tools to measure T-cell responses in humans now creates a situation in which known lipid antigens can be developed as immunodiagnostic and immunotherapeutic reagents for tuberculosis disease.
引用
收藏
页码:138 / 153
页数:16
相关论文
共 50 条
[31]   CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells [J].
Sidobre, S ;
Kronenberg, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 268 (01) :107-121
[32]   Conservation of CD1 protein expression patterns in the chicken [J].
Ly, Nary ;
Danzl, Nicole M. ;
Wang, Jing ;
Zajonc, Dirk M. ;
Dascher, Christopher C. .
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2010, 34 (02) :123-132
[33]   Analysis of the reptile CD1 genes: evolutionary implications [J].
Yang, Zhi ;
Wang, Chunyan ;
Wang, Tao ;
Bai, Jianhui ;
Zhao, Yu ;
Liu, Xuhan ;
Ma, Qingwei ;
Wu, Xiaobing ;
Guo, Ying ;
Zhao, Yaofeng ;
Ren, Liming .
IMMUNOGENETICS, 2015, 67 (5-6) :337-346
[34]   Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences [J].
Niazi, Kayvan R. ;
Ochoa, Maria-Teresa ;
Sieling, Peter A. ;
Rooke, Nanette E. ;
Peter, Anna K. ;
Mollahan, Pamela ;
Dickey, Micah ;
Rabizadeh, Shahrooz ;
Rea, Thomas H. ;
Modlin, Robert L. .
IMMUNOLOGY, 2007, 122 (04) :522-531
[35]   Inhibition of groups 1 and 2 CD1 molecules on human dendritic cells by Leishmania species [J].
Donovan, M. J. ;
Jayakumar, A. ;
McDowell, M. A. .
PARASITE IMMUNOLOGY, 2007, 29 (10) :515-524
[36]   Basic science for the clinician 35 -: CD1, invariant NKT (iNKT) cells, and γδ T-cells [J].
Sigal, LH .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (06) :336-339
[37]   The ins and outs of CD1 molecules: Bringing lipids under immunological surveillance [J].
Gumperz, JE .
TRAFFIC, 2006, 7 (01) :2-13
[38]   Structure and immunological functions of human CD1 molecules [J].
Tourne, Sylvie ;
Hanau, Daniel ;
de la Salle, Henri .
HEMATOLOGIE, 2006, 12 (06) :412-423
[39]   T lymphocyte recognition of human group 1 CD1 molecules: Implications for innate and acquired immunity [J].
Sugita, M ;
Brenner, MB .
SEMINARS IN IMMUNOLOGY, 2000, 12 (06) :511-516
[40]   CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver [J].
Tony Kenna ;
Margaret O’Brien ;
Andrew E. Hogan ;
Mark A. Exley ;
Steven A. Porcelli ;
John E. Hegarty ;
Cliona O’Farrelly ;
Derek G. Doherty .
Cancer Immunology, Immunotherapy, 2007, 56 :563-572